CAS No.: 51-34-3
Specification: 99%
Appearance: White powder
MOQ: 0.1KG
Normal Package: 1kg/Aluminum foil bag,25kg/Fiber drum
Normal Payment: T/T, L/C, Paypal, Western Union
Lead Time: 3~5 Days
Scopolamine also known as levo-duboisine or burundanga,sold as Scopoderm, is a tropane alkaloid drug with muscarinic antagonist effects. It is among the secondary metabolites of plants from Solanaceae (nightshade) family of plants, such as henbane, jimson weed(Datura), angel's trumpets (Brugmansia), and corkwood (Duboisia). Scopolamine exerts its effects by acting as a competitive antagonist atmuscarinic acetylcholine receptors; it is thus classified as an anticholinergic, antimuscarinic drug. Although it is usually referred to as a nonspecific antagonist, there is indirect evidence for m1-receptor subtype specificity. We have two kinds about this product:
Here is the Specification forScopolamine Hydrobromide
Product Name: Scopolamine Hydrobromide |
||
Analysis |
Specification |
Result |
Assay(C17H21NO4 HBr) |
99.0% Min |
99.7% |
Appearance |
Colorless crystal or white Crystalline Powder |
Complies |
Specific rotation |
-24-27 |
-25.3 |
Chemical reaction |
(1), (2), (4) positive reaction (3) infrared light absorption spectrum and the control patterns (spectrum, 288) |
Are positive responses Meet the requirements
|
Melting point |
195~199℃ |
196℃ |
Solution clarification |
Complies |
Complies |
PH |
4.0-5.5 |
4.55 |
Other alkaloids |
Complies |
Complies |
Easy oxide |
Complies |
Complies |
Loss on Drying |
13.0% Max |
9.7% |
Conclusion: Complies with the standard CP 2010. |
Here is the Specification forScopolamine
Product Name: Scopolamine |
|||
Items |
Specification |
Result |
Method |
Appearance colour |
White, almost white, colourless |
Complies |
Visual test |
Appearance shape |
Powder or crystals |
Powder |
Visual test |
Solubility in ethanol 96%(V/V) |
Freely soluble |
Complies |
Visual test |
Solubility in water(Visual test) |
Soluble |
Complies |
Visual test |
Melting point |
66-70℃ |
70℃ |
Capillary method |
Specific optical rotation [alpha]20/D calculated with reference to the solvent-free Substance |
-39.0 - -33.0° |
-36.2° |
/ |
IR spectrum |
Corresponding to reference spectrum |
Complies |
IR spectrophotometry |
UV spectrum
|
Corresponding to reference spectrum |
Complies |
UV/VIS spectrophotometry |
A 1%/1cm(257 nm) calculated with reference to the solvent-free substance |
5.9-6.5 |
6.1 |
UV/VIS spectrophotometry
|
Retention times |
the retention time of the principal peak obtained with the test sample is the same as that obtained with the reference standard |
Complies |
HPLC Liquid chromatography |
Rf values principal spots |
the Rf value of the principal spot obtained with the test substance must correspond to that |
Complies |
Thin-layer chromatography |
Norscopolamine |
0.5% Max |
0.1% |
Liquid chromatography |
Any other Impurity |
0.10% Max |
0.05% |
Liquid chromatography |
Total of all Impurities |
0.5% Max |
0.1% |
Liquid chromatography |
Total of all subsidiary spots |
0.5% Max |
0.5% |
TLC |
Any other impurity |
0.10% Max |
0.05% |
Liquid chromatography |
tert. -butyl methyl ether |
3000ppm Max |
700ppm |
GC |
Total of 2-methyl-1-butanol and 3-methyl-1-butanol |
500ppm Max |
50ppm |
GC |
Toluene |
100ppm Max |
10ppm |
GC |
Pentanol-1 |
500ppm Max |
50ppm |
GC |
Analytical procedure not supplied |
Meets the requirements |
Complies |
USP < 467 > |
Water |
0.5% Max |
0.1% |
Blamperometric Karl Fischer titration |
Sulphated ash |
0.1% Max |
Complies |
Limit test |
Calculated with reference to solvent-free substance |
98.5-101.0% |
99.3% |
Titration with perchloric acid |
Calculated with reference to solvent-free substance |
99.0-100.5% |
99.3% |
Titration with perchloric acid |
Calculated with reference to solvent-free substance |
98.0-102.0% |
99.3% |
Liquid chromatography |
Conclusion: Product corresponds with the requirements of current Ph.Eur. |
Main Function
1. It is a peripheral role stronger anticholinergic activity, blocking M choline receptor.
2. Scopolamine hydrobromide powder 99% is used clinically as drug of antegen-eral anesthesia, and for motion sickness, shaking palsy, manic psychosis and organophosphate poisoning.
Your email address will not be published. Required fields are marked *